Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer
Authors:
- Jingmei LiJLJingmei Li
- Louise ErikssonLELouise Eriksson
- Keith HumphreysKHKeith Humphreys
- Kamila CzeneKCKamila Czene
- Jianjun LiuJLJianjun Liu
- Rulla M TamimiRTRulla M Tamimi
- Sara LindströmSLSara Lindström
- David J HunterDHDavid J Hunter
- Celine M VachonCVCeline M Vachon
- Fergus J CouchFCFergus J Couch
- Christopher G ScottCSChristopher G Scott
- Pagona LagiouPLPagona Lagiou
Open Access
- 9 March 2010
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 12 (2) , R19
Abstract
Introduction: Several studies have examined the effect of genetic variants in genes involved in the estrogen metabolic pathway on mammographic density, but the number of loci studied and the sample sizes evaluated have been small and pathways have not been evaluated comprehensively. In this study, we evaluate the association between mammographic density and genetic variants of the estrogen metabolic pathway. Methods: A total of 239 SNPs in 34 estrogen metabolic genes were studied in 1,731 Swedish women who participated in a breast cancer case-control study, of which 891 were cases and 840 were controls. Film mammograms of the medio-lateral oblique view were digitalized and the software Cumulus was used for computer-assisted semi-automated thresholding of mammographic density. Generalized linear models controlling for possible confounders were used to evaluate the effects of SNPs on mammographic density. Results found to be nominally significant were examined in two independent populations. The admixture maximum likelihood-based global test was performed to evaluate the cumulative effect from multiple SNPs within the whole metabolic pathway and three subpathways for androgen synthesis, androgen-to-estrogen conversion and estrogen removal. Results: Genetic variants of genes involved in estrogen metabolism exhibited no appreciable effect on mammographic density. None of the nominally significant findings were validated. In addition, global analyses on the overall estrogen metabolic pathway and its subpathways did not yield statistically significant results. Conclusions: Overall, there is no conclusive evidence that genetic variants in genes involved in the estrogen metabolic pathway are associated with mammographic density in postmenopausal women.Keywords
This publication has 47 references indexed in Scilit:
- Genotype ImputationAnnual Review of Genomics and Human Genetics, 2009
- Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI?Annals of Oncology, 2009
- Can genes for mammographic density inform cancer aetiology?Nature Reviews Cancer, 2008
- Association of Mammographic Density with the Pathology of Subsequent Breast Cancer among Postmenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2008
- Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidenceBreast Cancer Research, 2008
- Mammographic density, breast cancer risk and risk predictionBreast Cancer Research, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancerNature Genetics, 2007
- A common coding variant in CASP8 is associated with breast cancer riskNature Genetics, 2007
- The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in WomenJACC, 2006